Wang QM - Search Results

1

Estrogen analogues: promising target for prevention and treatment of esophageal squamous cell carcinoma in high risk areas.

Wang QM, Yuan L, Qi YJ, Ma ZY, Wang LD. Wang QM, et al. Among authors: wang ld. Med Sci Monit. 2010 Jul;16(7):HY19-22. Med Sci Monit. 2010. PMID: 20581783

2

Expression of MUC1 in esophageal squamous-cell carcinoma and its relationship with prognosis of patients from Linzhou city, a high incidence area of northern China.

Song ZB, Gao SS, Yi XN, Li YJ, Wang QM, Zhuang ZH, Wang LD. Song ZB, et al. Among authors: wang qm, wang ld. World J Gastroenterol. 2003 Mar;9(3):404-7. doi: 10.3748/wjg.v9.i3.404. World J Gastroenterol. 2003. PMID: 12632485 Free PMC article.

3

Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China.

Wang QM, Qi YJ, Jiang Q, Ma YF, Wang LD. Wang QM, et al. Among authors: wang ld. Med Oncol. 2011 Mar;28(1):188-93. doi: 10.1007/s12032-010-9457-8. Epub 2010 Mar 2. Med Oncol. 2011. PMID: 20195802

4

Erlotinib-based perioperative adjuvant therapy for a case of unresectable stage IIIA (N2) nonsmall cell lung cancer.

Wang Q, Wang H, Li P, Zhu H, He C, Wei B, Ma J, Ma Z. Wang Q, et al. Am J Med Sci. 2010 Oct;340(4):321-5. doi: 10.1097/MAJ.0b013e3181e59ac2. Am J Med Sci. 2010. PMID: 20601859

5

[Research progresses of albumin-bound paclitaxel in the treatment of non-small cell lung cancer].

Li P, Wang Q, Wang H, Ma Z. Li P, et al. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):748-52. doi: 10.3779/j.issn.1009-3419.2010.07.16. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673493 Free PMC article. Review. Chinese. No abstract available.

6

[The role of adjuvant chemotherapy in operable non-small cell lung cancer].

Yan X, Zhu H, Wang H, Wang Q, Li P, Ma Z. Yan X, et al. Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):281-5. doi: 10.3779/j.issn.1009-3419.2011.03.15. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21426675 Free PMC article. Review. Chinese.

7

MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.

Wang Q, Wang S, Wang H, Li P, Ma Z. Wang Q, et al. Exp Biol Med (Maywood). 2012 Mar;237(3):227-35. doi: 10.1258/ebm.2011.011192. Epub 2012 Feb 16. Exp Biol Med (Maywood). 2012. PMID: 22345301 Review.

8

Differential efficacy of gefitinib across age groups in treatment of advanced lung adenocarcinoma.

Wang H, Zhang G, Li P, Yan X, Wang Q, Zhu H, Qi G, Fan Q, Ma Z. Wang H, et al. Pharmazie. 2012 Jan;67(1):80-5. Pharmazie. 2012. PMID: 22393836

9

Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.

Qi YJ, Ward DG, Pang C, Wang QM, Wei W, Ma J, Zhang J, Lou Q, Shimwell NJ, Martin A, Wong N, Chao WX, Wang M, Ma YF, Johnson PJ. Qi YJ, et al. Among authors: wang qm, wang m. Proteomics. 2014 Feb;14(2-3):186-95. doi: 10.1002/pmic.201300226. Proteomics. 2014. PMID: 24259486

10

[Expression and significance of bone sialoprotein(BSP) in esophageal squamous cell carcinoma].

Tang H, Wang H, Wang L, Wang Q, Qin Y, Wang X, Luo S. Tang H, et al. Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):602-5. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25430027 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters